Ketirix (Ketotifen Hydrogen Fumarate)

Ketotifen hydrogen fumarate works by stabilizing mast cells in the ocular tissues, which limits the release of histamine and other inflammatory mediators. It also blocks histamine H1 receptors, decreasing vasodilation, vascular permeability and sensory nerve activation that cause itching and redness.

The dosing regimen for Ketirix is determined by the prescribing clinician based on the severity of the allergic eye condition and patient factors. Typical instructions involve one or two drops per affected eye, but the exact frequency and duration should follow the healthcare professional’s recommendation.

Safety data for ketotifen hydrogen fumarate in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their physician before using Ketirix.

To order Ketirix, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketirix combines mast‑cell stabilization with H1‑receptor antagonism, offering both preventive and symptomatic relief. Compared with agents that act solely as H1 antagonists, such as olopatadine, Ketirix may provide longer‑lasting control of allergic inflammation, though individual response varies and choice should be guided by the prescriber.

Ketirix should be stored at room temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations. Keep the vial tightly closed when not in use to maintain sterility.

Ketirix is applied as eye drops. The patient should wash hands, tilt the head back, pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption.

Serious but rare risks include severe allergic reactions such as anaphylaxis, corneal ulceration or keratitis, and a significant rise in intra‑ocular pressure that could threaten vision. Any sudden worsening of eye pain, vision loss or systemic allergic symptoms should prompt immediate medical attention.

Ketirix should be avoided in individuals with known hypersensitivity to ketotifen, its salts, or any excipients in the formulation. Patients with active ocular infections, uncontrolled glaucoma, or those who cannot remove contact lenses before administration should consult their eye care professional before use.